Endometrial carcinoma expresses an increased cathepsin B/D ratio
Authors:
- Paul H. LimaPLPaul H. Lima
- Lisa RodgersLRLisa Rodgers
- Charles H. BlomquistCBCharles H. Blomquist
- Levi S. DownsLDLevi S. Downs
- 1 January 2008
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 108 (1) , 84-89
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Pericellular cathepsin B and malignant progressionCancer and Metastasis Reviews, 2003
- Cathepsin D Specifically Cleaves the Chemokines Macrophage Inflammatory Protein-1α, Macrophage Inflammatory Protein-1β, and SLC That Are Expressed in Human Breast CancerThe American Journal of Pathology, 2003
- Low levels of cathepsin D are associated with a poor prognosis in endometrial cancerBritish Journal of Cancer, 1999
- Lysosomal protease cathepsin D is a prognostic marker in endometrial cancerBritish Journal of Cancer, 1996
- Prognostic value of cathepsin D in breast cancer: comparison of immunohistochemical and immunoradiometric detection methods.Journal of Clinical Pathology, 1996
- Cathepsin B, L, and D activities in colorectal carcinomas: relationship with clinico-pathological parametersCancer Letters, 1995
- Expression of pancreatic trypsinogen/trypsin and cathepsin B in human cholangiocarcinomas and hepatocellular carcinomasHuman Pathology, 1995
- Figo stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: An analysis of 1973‐87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vaginaSeminars in Surgical Oncology, 1994
- Protease activities in gastric cancer tissuesClinica Chimica Acta, 1990